Literature DB >> 10716501

Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume.

A Vigano1, S Vella, M Saresella, A Vanzulli, D Bricalli, S Di Fabio, P Ferrante, M Andreotti, M Pirillo, L G Dally, M Clerici, N Principi.   

Abstract

DESIGN: Despite significant rises in total CD4 T cells, the process of immune reconstitution in adults with HIV infection treated with potent antiretroviral treatment results in a rather slow increase in phenotypically naive lymphocytes. In children more than in adults, thymic function may be at least partly restored when disease-induced immunosuppression is attenuated by pharmacological means.
METHODS: Twenty-five vertically infected and antiretroviral-experienced [zidovudine (ZDV)/ZDV plus didanosine (ddl)] children were prospectively followed during 12 months of treatment with lamivudine (3TC), stavudine (d4T) and indinavir (IDV). The plasma HIV viral load and phenotypic and functional cellular immunity-defining parameters were examined. The relationship between the degree of immune reconstitution and thymus volume assessed by nuclear magnetic resonance was also examined.
RESULTS: An early and steep increase in CD45RA+62L+ T cells was observed in parallel with a sustained decrease in plasma HIV RNA levels and a significant rise in total CD4 T cells. This increase was significantly greater than that observed in CD4+CD45RO+ T cells. Analysis of the CD4 T cell receptor (TCR) beta repertoire and T helper function showed the ability to reconstitute families almost completely absent at baseline, and a substantial improvement of antigen-specific responses by peripheral blood lymphocytes. The rise in CD4 cells and in CD4+CD45RA+62L+ T cells was statistically associated with changes in thymus size observed over time.
CONCLUSION: These data suggest a relevant contribution of the thymus to reconstitution of the peripheral pool of T cells in vertically HIV-infected children treated with potent antiretroviral regimens.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10716501     DOI: 10.1097/00002030-200002180-00007

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  21 in total

1.  Low thymic output in the 22q11.2 deletion syndrome measured by CCR9+CD45RA+ T cell counts and T cell receptor rearrangement excision circles.

Authors:  K Lima; T G Abrahamsen; I Foelling; S Natvig; L P Ryder; R W Olaussen
Journal:  Clin Exp Immunol       Date:  2010-05-10       Impact factor: 4.330

Review 2.  Thymic function in HIV infection.

Authors:  Rohan Hazra; Crystal Mackall
Journal:  Curr HIV/AIDS Rep       Date:  2005-02       Impact factor: 5.071

3.  Thymic function-related markers within the thymus and peripheral blood: Are they comparable?

Authors:  María Victoria Arellano; Antonio Ordóñez; Ezequiel Ruiz-Mateos; Santiago R Leal-Noval; Sonia Molina-Pinelo; Ana Hernández; Alejandro Vallejo; Rafael Hinojosa; Manuel Leal
Journal:  J Clin Immunol       Date:  2006-01       Impact factor: 8.317

4.  Molecular and cellular mechanisms of Mycobacterium avium-induced thymic atrophy.

Authors:  Margarida Borges; Palmira Barreira-Silva; Manuela Flórido; Michael B Jordan; Margarida Correia-Neves; Rui Appelberg
Journal:  J Immunol       Date:  2012-08-24       Impact factor: 5.422

Review 5.  Immune reconstitution and vaccination outcome in HIV-1 infected children: present knowledge and future directions.

Authors:  Alberto Cagigi; Nicola Cotugno; Carlo Giaquinto; Luciana Nicolosi; Stefania Bernardi; Paolo Rossi; Iyadh Douagi; Paolo Palma
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

6.  Assessment of thymic activity in human immunodeficiency virus-negative and -positive adolescents by real-time PCR quantitation of T-cell receptor rearrangement excision circles.

Authors:  Thao Pham; Marvin Belzer; Joseph A Church; Christina Kitchen; Craig M Wilson; Steven D Douglas; Yongzhi Geng; Monica Silva; Richard M Mitchell; Paul Krogstad
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

Review 7.  The role of non-nucleoside reverse transcriptase inhibitors in children with HIV-1 infection.

Authors:  S Maddocks; D Dwyer
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

8.  Measles and Rubella Seroprevalence Among HIV-infected and Uninfected Zambian Youth.

Authors:  Catherine G Sutcliffe; Kelly Searle; Hellen K Matakala; Michelle P Greenman; Kaitlin Rainwater-Lovett; Philip E Thuma; William J Moss
Journal:  Pediatr Infect Dis J       Date:  2017-03       Impact factor: 2.129

9.  Growth hormone enhances thymic function in HIV-1-infected adults.

Authors:  Laura A Napolitano; Diane Schmidt; Michael B Gotway; Niloufar Ameli; Erin L Filbert; Myra M Ng; Julie L Clor; Lorrie Epling; Elizabeth Sinclair; Paul D Baum; Kai Li; Marisela Lua Killian; Peter Bacchetti; Joseph M McCune
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

10.  Thymic volume is associated independently with the magnitude of short- and long-term repopulation of CD4+ T cells in HIV-infected adults after highly active antiretroviral therapy (HAART).

Authors:  E Ruiz-Mateos; A Rubio; A Vallejo; R De la Rosa; A Sanchez-Quijano; E Lissen; M Leal
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.